Welcome to the international HTA database

Showing [23537 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor (cystic fibrosis, 6 years and older, with G551D mutation) - Addendum to Commission A19-65]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for average length of stay in the intensive care unit for COVID-19
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor (combination with tezacaftor/ivacaftor, cystic fibrosis, 12 years and older, with F508del mutation, heterozygous) - Addendum to Commission A19-71]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for COVID-19 clinical samples
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: protecting health care workers' (HCW) families at home
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Andexanet alfa (acute major bleeding) - Addendum to Commission A19-76]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for asymptomatic transmission of COVID-19
2020	Ontario Health	Automated CT perfusion imaging to aid in the selection of patients with acute ischemic stroke for mechanical thrombectomy
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[CD34+ cells (beta thalassaemia) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	Health Information and Quality Authority (HIQA)	Rapid health technology assessment of alternative diagnostic testing approaches for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2020	Ontario Health	Home narrowband ultraviolet B phototherapy for photoresponsive skin conditions
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mandibular advancement devices in mild to moderate obstructive sleep apnoea in adults]
2020	Health Information and Quality Authority (HIQA)	Evidence summary of placental transfer of antibodies
2020	Ontario Health	Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: corticosteroids for hospitalized patients
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Belimumab (SLE) - Benefit assessment according to §35a Social Code Book V]
2019	National Institute for Health and Care Excellence (NICE)	Endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysms. NICE interventional procedures guidance 658
2019	National Institute for Health and Care Excellence (NICE)	Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer. NICE interventional procedures guidance 659
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019	National Institute for Health and Care Excellence (NICE)	Transurethral laser ablation for recurrent non-muscle-invasive bladder cancer. NICE interventional procedures guidance 656
2019	National Institute for Health and Care Excellence (NICE)	Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids. NICE interventional procedures guidance 657
2019	National Institute for Health and Care Excellence (NICE)	Cardiac contractility modulation device implantation for heart failure. NICE interventional procedures guidance 655
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: The Argus II retinal implant]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cleft lip and palate: does using the nasoalveolar molding method before surgery lead to better results?]
2019	National Institute for Health and Care Excellence (NICE)	Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction. NICE interventional procedures guidance 653
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	HPV testing for primary cervical cancer screening: a health technology assessment
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cancer: can concomitant music therapy contribute to better treatment results?]
2019	National Institute for Health and Care Excellence (NICE)	Reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia. NICE interventional procedures guidance 654
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Internet-delivered cognitive behavioural therapy for major depressive disorder and anxiety disorders: a health technology assessment
2019	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Rehabilitation for adults with traumatic brain injury]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[How do non-drug interventions influence coping with suicidal crises in unipolar depression?]
2019	National Institute for Health and Care Excellence (NICE)	Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI. NICE interventional procedures guidance 650
2019	NIHR Health Technology Assessment programme	Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: approach to managing access to cancer care: a review of the literature and practices]
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Axicabtagene ciloleucel for large B-cell lymphoma: clinical report
2019	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Risk and needs assessment regarding reoffending in adolescents]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Idiopathic scoliosis: is video rasterstereography an adequate replacement for radiography in aftercare?]
2019	National Institute for Health and Care Excellence (NICE)	Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg. NICE interventional procedures guidance 651
2019	NIHR Health Technology Assessment programme	Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
2019	National Institute for Health and Care Excellence (NICE)	Bronchoscopic thermal vapour ablation for upper-lobe emphysema. NICE interventional procedures guidance 652
2019	National Institute for Health and Care Excellence (NICE)	Therapeutic hypothermia for acute ischaemic stroke. NICE interventional procedures guidance 647
2019	NIHR Health Technology Assessment programme	Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019	National Institute for Health and Care Excellence (NICE)	Collagen paste for closing an anal fistula. NICE interventional procedures guidance 648
2019	NIHR Health Technology Assessment programme	Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2019	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Effectiveness and safety of epicardial closure of left atrial appendage using clips by minimally invasive surgery for thromboembolism prevention in patients with atrial fibrillation]
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Genome-wide sequencing: ethical considerations
2019	National Institute for Health and Care Excellence (NICE)	Percutaneous mitral valve leaflet repair for mitral regurgitation. NICE interventional procedures guidance 649
2019	NIHR Health Technology Assessment programme	Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]
2019	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Validity, clinical utility and safety of the next-generation sequencing (NGS) genomic platform FoundationOne® in non-small cell lung cancer and other solid tumors]
2019	National Institute for Health and Care Excellence (NICE)	Endoscopic ablation for an anal fistula. NICE interventional procedures guidance 645
2019	NIHR Health Technology Assessment programme	Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia]
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Flash glucose monitoring system for people with type 1 or type 2 diabetes: a health technology assessment
2019	National Institute for Health and Care Excellence (NICE)	Endoscopic ablation for a pilonidal sinus. NICE interventional procedures guidance 646
2019	NIHR Horizon Scanning Centre (NIHR HSC)	An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019	Norwegian Institute of Public Health (NIPH)	Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: breast tomosynthesis and breast cancer screening]
2019	National Institute for Health and Care Excellence (NICE)	Radially emitting laser fibre treatment of an anal fistula. NICE interventional procedures guidance 644
2019	NIHR Health Technology Assessment programme	Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2019	National Institute for Health and Care Excellence (NICE)	High-intensity focused ultrasound for symptomatic benign thyroid nodules. NICE interventional procedures guidance 643
2019	National Institute for Health and Care Excellence (NICE)	Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal. NICE interventional procedures guidance 642
2019	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Stereotactic neurosurgery frameless. The iSYS1® Robotic device]
2019	Norwegian Institute of Public Health (NIPH)	Disease modifying treatments for relapsing remitting multiple sclerosis. A health economic evaluation
2019	National Institute for Health and Care Excellence (NICE)	Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer. NICE interventional procedures guidance 638
2019	Norwegian Institute of Public Health (NIPH)	Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment
2019	National Institute for Health and Care Excellence (NICE)	Laparoscopic cerclage for cervical incompetence to prevent late miscarriage or preterm birth. NICE interventional procedures guidance 639
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2019	National Institute for Health and Care Excellence (NICE)	Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis. NICE interventional procedures guidance 640
2019	Andalusian Health Technology Assessment Area (AETSA)	PET usefulness in non-oncological indications
2019	Norwegian Institute of Public Health (NIPH)	Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019	National Institute for Health and Care Excellence (NICE)	Platelet-rich plasma injections for knee osteoarthritis. NICE interventional procedures guidance 637
2019	Haute Autorite de sante (HAS)	[Assessment of pulp wound protection by direct pulp capping]
2019	Andalusian Health Technology Assessment Area (AETSA)	Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019	Norwegian Institute of Public Health (NIPH)	Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
2019	National Institute for Health and Care Excellence (NICE)	Ex-situ machine perfusion for extracorporeal preservation of livers for transplantation. NICE interventional procedures guidance 636
2019	Norwegian Institute of Public Health (NIPH)	Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk – Part 2. Health economic evaluation
2019	NIHR Health Technology Assessment programme	Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019	Norwegian Institute of Public Health (NIPH)	Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Canagliflozin, empagliflozin and dapagliflozin in type 2 diabetes patients]
2019	Norwegian Institute of Public Health (NIPH)	Hyperbaric oxygen therapy for osteonecrosis
2019	NIHR Public Health Research (PHR) programme	Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence
2019	NIHR Health Technology Assessment programme	Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2019	Finnish Coordinating Center for Health Technology Assessment (FinCCHTA)	[Surgical smoke during operations - the risks to personnel, and the protective measures needed]
2019	Adelaide Health Technology Assessment (AHTA)	Alpha Thalassaemia genetic testing
2019	NIHR Health Technology Assessment programme	Developing and evaluating a tool to measure general practice productivity: a multimethod study
2019	NIHR Health Technology Assessment programme	Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Axicabtagene ciloleucel (PMBCL)]
2019	Swiss Federal Office of Public Health (FOPH)	Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures
2019	NIHR Health Technology Assessment programme	An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019	Swiss Federal Office of Public Health (FOPH)	Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2019	NIHR Health Services and Delivery Research programme	Innovation to enhance health in care homes: rapid evidence synthesis
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Bevacizumab in age-related macular degeneration]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thiazolidinediones for type 2 diabetes mellitus]
2019	Institute for Clinical Effectiveness and Health Policy (IECS)	[Canagliflozin, empagliflozin and dapagliflozin (SGLT-2) for patients with type 2 diabetes]
2019	NIHR Health Technology Assessment programme	A peer-led physical activity intervention in schools for adolescent girls: a feasibility RCT
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Transmural fixation of aortic endograft adjunct to endovascular aneurysm repair using helical anchors
2019	Andalusian Health Technology Assessment Area (AETSA)	[Blood test for the early diagnosis of pancreatic cancer. CancerSEEK]